Stay updated with breaking news from Nasdaq Txg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]
10x Genomics, Inc. (NASDAQ:TXG – Free Report) – William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior forecast of […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by Stifel Nicolaus from $63.00 to $53.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity Group reduced their price target […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from $63.00 to $53.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 103.85% from the […]